Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer
Medical Sciences · 15.09.2023 · 11 (3) · 60
DOI: 10.3390/medsci11030060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 15.09.2023. Verfasst von Joel Petit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery, John Hunter Hospital, Newcastle, NSW 2305, Australia. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Colonic Diseases, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Newcastle RHD stipend, the Hunter Medical Research Institute, AMP Foundation Tomorrow Makers, NSW Health Pathology North.
Abstract (Originalsprache)
Circulating tumour DNA biomarkers are an expanding field in oncology research that offer great potential but are currently often limited in value by overall cost. The aim of this study was to evaluate the efficacy of a novel multi-gene methylation blood test for the identification of colorectal cancer and throughout the spectrum of colorectal disease. Participants were recruited either prior to resection for known CRC or prior to screening colonoscopy after a positive faecal immunochemical test. Blood was collected from participants prior to their procedure being performed. The plasma was separated, and multiplex MethylLight droplet digital PCR was used to analyse for the presence of four methylated genes: SDC2, NPY, IKZF1 and SEPT9. A total of 537 participants underwent analysis. The SDC2/NPY genes showed a sensitivity of 33–54% and a specificity of 72–96%, whilst the IKZF1/SEPT9 genes showed a sensitivity of 19–42% and a specificity of 88–96%. Combining the two tests did not significantly increase the test accuracy. The sensitivity for advanced adenoma was 2–15%. There was a significant difference in the frequency of detectable methylation between the participants with CRC and those without CRC. However, neither the sensitivity nor the specificity was superior to current diagnostic screening tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Surgery, John Hunter Hospital, Newcastle, NSW 2305, Australia.
- School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW 2305, Australia.
- Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2305, Australia.
- School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2305, Australia.
- Pathology North, Newcastle, NSW 2305, Australia.
ORCID-Profile: Joel Petit, Peter Pockney, Rodney J Scott
Förderung
- University of Newcastle RHD stipend, the Hunter Medical Research Institute
- AMP Foundation Tomorrow Makers
- NSW Health Pathology North
- John Hunter Hospital Charitable Trust
Zitieren
APA
Petit, J., Carroll, G., Williams, H., Pockney, P., & Scott, R. J. (2023). Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer. Medical Sciences, 11(3), 60. https://doi.org/10.3390/medsci11030060
Vancouver
Petit J, Carroll G, Williams H, Pockney P, Scott RJ. Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer. Medical Sciences. 2023;11(3):60. doi:10.3390/medsci11030060
BibTeX
@article{Petit2023,
author = {Petit, Joel and Carroll, Georgia and Williams, Henry and Pockney, Peter and Scott, Rodney J},
title = {Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer},
journal = {Medical Sciences},
year = {2023},
volume = {11},
number = {3},
pages = {60},
doi = {10.3390/medsci11030060}
}
EUVIMED